Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation

Summary

The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.

Timeline

Start

2009-11

Primary completion

2010-10

Completion

2010-10

Publications

• Results Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol. 2011 Oct;106(10):1803-12. doi: 10.1038/ajg.2011.162. Epub 2011 May 24.

Drugs

Indications